Inherent Health
Interleukin Genetics, Inc. introduced its new Inherent Health™ brand of genetic tests. The Inherent Health brand offers customers a full suite of affordable, easy-to-use and meaningful genetic tests in weight management, heart health, bone health and nutritional needs, as well as PST®, the periodontal disease risk assessment test. The products permit focused, personalized guidance for individuals looking for insights on specific lifestyle changes that can be made based on their genetic results to impact their health and wellness. The Inherent Health brand of genetic tests is now available online at www.inherenthealth.com.
Weight Management Test offers a genetics-based program that will determine whether an individual is likely to benefit more from a low fat, low carbohydrate or balanced calorie reduced diet, and whether an individual is likely to obtain greater benefit from normal or more vigorous exercise to most efficiently lose weight. The test provides new information beyond traditional assessments to help individuals understand the genetic factors that lead to weight gain.
Heart Health Genetic Test that identifies a person’s genetic predisposition to heart attack based on inflammation. The genetic analysis identifies individuals that have a lifelong tendency to overproduce certain chemicals in the body that lead to inflammation. Overproduction of these chemicals can start a chain reaction that ultimately may lead to a heart attack.
Nutritional Needs Genetic Test that identifies DNA variations in genes crucial to B-vitamin metabolism and the ability to manage oxidative stress. Individuals that show suboptimal results for the genes can be at increased risk for ineffective utilization of B-vitamins and potential for cell damage caused by oxidative stress.
Periodontal Disease (PST®) Genetic Test identifies an individual’s predisposition for tooth loss caused by over-expression of inflammation and subsequent risk for periodontal disease. The test is currently available through dentists.
Bone Health Genetic Test will be available during the second half of this year and will identify whether an individual is more likely to be susceptible to spine fractures and low bone mineral density associated with osteoporosis.